CD274 and neoplasm: In a study by Vital et al., where 1% cutoff for PD-L1 (clone SP142) positivity was applied, the authors identified 13% of PD-L1 positive AciCCs and 20% of tumours with PD-L1 positive infiltrating immune cells [29].